Real-world data on finerenone use in indian kidney patients
NCT ID NCT06763146
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 34 times
Summary
This study reviews medical records of 1200 Indian adults with chronic kidney disease and type 2 diabetes who started finerenone between 2022 and 2024. Researchers will describe how doctors prescribed the drug, dose changes, and effects on kidney function and potassium levels. The goal is to understand real-world usage patterns, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Many locations
Multiple Locations, India
Conditions
Explore the condition pages connected to this study.